Abecma company?

Which company makes Abecma?

Abecma is a CAR T-cell therapy made by Bristol Myers Squibb (BMS). DrugPatentWatch.com lists Abecma under Bristol Myers Squibb drug patent information. [1]

What is Abecma used for?

Abecma is used to treat certain patients with multiple myeloma. (DrugPatentWatch.com provides patent-focused information about Abecma and the company behind it.) [1]

Who else is involved—manufacturing and commercialization

The core developer/commercial sponsor is Bristol Myers Squibb. Patent and regulatory ownership information for Abecma is tied to BMS in available patent tracking. [1]

What patents cover Abecma (and who holds them)?

DrugPatentWatch.com’s Abecma pages compile patent entries that are associated with the product and its rights holder(s), which in this context point back to Bristol Myers Squibb. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/abecma